Causality in genetics : The gradient of genetic effects and back to Koch's postulates of causality

Circulation Research

Volumn 114, Issue 2, 2014, Pages e18-e21

  Marian, Ali J ^a  

^a INSTITUTE OF MOLECULAR BIOLOGY   (Armenia)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; MESSENGER RNA; MUTANT PROTEIN; NUCLEOTIDE; SPACER DNA; UBIQUITIN PROTEIN LIGASE E3; MUSCLE PROTEIN; UBIQUITIN PROTEIN LIGASE;

BIOLOGICAL ACTIVITY; BIOLOGICAL FUNCTIONS; CARDIOMYOPATHY; DNA MARKER; EFFECT SIZE; ENVIRONMENTAL FACTOR; EXOME; GENE DELETION; GENE INSERTION; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC CONSERVATION; GENETIC DISORDER; GENETIC EPIDEMIOLOGY; GENETIC LINKAGE; GENETIC SCREENING; GENETIC VARIABILITY; GENOME ANALYSIS; HEART ARRHYTHMIA; HEART RATE; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE TACHYCARDIA; HEREDITY; HUMAN; HUMAN GENOME; HYPERTROPHIC CARDIOMYOPATHY; INCIDENTAL FINDING; LETTER; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PATHOGENESIS; PENETRANCE; PHENOTYPIC VARIATION; POPULATION; POPULATION GROWTH; PREVALENCE; PRIORITY JOURNAL; PROTEIN STRUCTURE; STRUCTURE ANALYSIS; ANIMAL; FEMALE; GENETICS; MALE; METABOLISM; MISSENSE MUTATION; NOTE;

ANIMALS; CARDIOMYOPATHY, HYPERTROPHIC; FEMALE; GENE DELETION; HUMANS; MALE; MUSCLE PROTEINS; MUTATION, MISSENSE; UBIQUITIN-PROTEIN LIGASES;

EID: 84897112970     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.114.302904     Document Type: Letter

References (28)

1. Marian AJ. Nature's genetic gradients and the clinical phenotype. Circ Cardiovasc Genet. 2009;2:537-539.
2. Marian AJ, Belmont J. Strategic approaches to unraveling genetic causes of cardiovascular diseases. Circ Res. 2011;108:1252-1269.
3. Seidman CE, Seidman JG. Identifying sarcomere gene mutations in hypertrophic cardiomyopathy: A personal history. Circ Res. 2011;108:743-750.
4. Harris SP, Lyons RG, Bezold KL. In the thick of it: HCM-causing mutations in myosin binding proteins of the thick filament. Circ Res. 2011;108:751-764.
5. Golbus JR, Puckelwartz MJ, Fahrenbach JP, Dellefave-Castillo LM, Wolfgeher D, McNally EM. Population-based variation in cardiomyopathy genes. Circ Cardiovasc Genet. 2012;5:391-399.
6. Bick AG, Flannick J, Ito K, et al. Burden of rare sarcomere gene variants in the Framingham and Jackson Heart Study cohorts. Am J Hum Genet. 2012;91:513-519.
7. Tennessen JA, Bigham AW, O'Connor TD, et al; Broad GO; Seattle GO; NHLBI Exome Sequencing Project. Evolution and functional impact of rare coding variation from deep sequencing of human exomes. Science. 2012;337:64-69.
8. Rodriguez G, Ueyama T, Ogata T, Czernuszewicz G, Tan Y, Dorn GW II, Bogaev R, Amano K, Oh H, Matsubara H, Willerson JT, Marian AJ. Molecular genetic and functional characterization implicate muscle- restricted coiled-coil gene (MURC) as a causal gene for familial dilated cardiomyopathy. Circ Cardiovasc Genet. 2011;4:349-358.
9. Chen SN, Czernuszewicz G, Tan Y, Lombardi R, Jin J, Willerson JT, Marian AJ. Human molecular genetic and functional studies identify TRIM63, encoding Muscle RING Finger Protein 1, as a novel gene for human hypertrophic cardiomyopathy. Circ Res. 2012;111:907-919.
10. Ploski R, Pollak A, Muller S, Franaszcyk M, Michalak E, Kosinska J, Stawinski P, Seggewiss H, Bilinska ZT. Does p.Q247X in trim63 cause human hypertrophic cardiomyopathy? Circ Res. 2013;XXX.
11. Abecasis GR, Altshuler D, Auton A, Brooks LD, Durbin RM, Gibbs RA, Hurles ME, McVean GA; 1000 Genomes Project Consortium. A map of human genome variation from population-scale sequencing. Nature. 2010;467:1061-1073.
12. Roy S, Ernst J, Kharchenko PV, et al. Identification of functional elements and regulatory circuits by drosophila modencode. Science. 2010;330:1787-1797.
13. Lappalainen T, Sammeth M, Friedländer MR, et al; Geuvadis Consortium. Transcriptome and genome sequencing uncovers functional variation in humans. Nature. 2013;501:506-511.
14. MacArthur DG, Balasubramanian S, Frankish A, et al; 1000 Genomes Project Consortium. A systematic survey of loss-of-function variants in human protein-coding genes. Science. 2012;335:823-828.
15. Keinan A, Clark AG. Recent explosive human population growth has resulted in an excess of rare genetic variants. Science. 2012;336:740-743.
16. Campbell CD, Chong JX, Malig M, Ko A, Dumont BL, Han L, Vives L, O'Roak BJ, Sudmant PH, Shendure J, Abney M, Ober C, Eichler EE. Estimating the human mutation rate using autozygosity in a founder population. Nat Genet. 2012;44:1277-1281.
17. Kong A, Frigge ML, Masson G, et al. Rate of de novo mutations and the importance of father's age to disease risk. Nature. 2012;488:471-475.
18. Novembre J, Johnson T, Bryc K, Kutalik Z, Boyko AR, Auton A, Indap A, King KS, Bergmann S, Nelson MR, Stephens M, Bustamante CD. Genes mirror geography within Europe. Nature. 2008;456:98-101.
19. Ng D, Johnston JJ, Teer JK, Singh LN, Peller LC, Wynter JS, Lewis KL, Cooper DN, Stenson PD, Mullikin JC, Biesecker LG; NIH IntramuralSequencing Center (NISC) Comparative Sequencing Program. Interpreting secondary cardiac disease variants in an exome cohort. Circ Cardiovasc Genet. 2013;6:337-346.
20. Jabbari J, Jabbari R, Nielsen MW, Holst AG, Nielsen JB, Haunsø S, Tfelt- Hansen J, Svendsen JH, Olesen MS. New exome data question the pathogenicity of genetic variants previously associated with catecholaminergic polymorphic ventricular tachycardia. Circ Cardiovasc Genet. 2013;6:481-489.
21. Flannick J, Beer NL, Bick AG, et al. Assessing the phenotypic effects in the general population of rare variants in genes for a dominant Mendelian form of diabetes. Nat Genet. 2013;45:1380-1385.
22. Rigato I, Bauce B, Rampazzo A, et al. Compound and digenic heterozygosity predicts life-time arrhythmic outcome and sudden cardiac death in desmosomal gene-related arrhythmogenic right ventricular cardiomyopathy. Circ Cardiovasc Genet. 2013 Sep26 [Epub ahead of print].
23. Xu T, Yang Z, Vatta M, et al; Multidisciplinary Study of Right Ventricular Dysplasia Investigators. Compound and digenic heterozygosity contributes to arrhythmogenic right ventricular cardiomyopathy. J Am Coll Cardiol. 2010;55:587-597.
24. Bezzina CR, Rook MB, Groenewegen WA, Herfst LJ, van der Wal AC, Lam J, Jongsma HJ, Wilde AA, Mannens MM. Compound heterozygosity for mutations (W156X and R225W) in SCN5A associated with severe cardiac conduction disturbances and degenerative changes in the conduction system. Circ Res. 2003;92:159-168.
25. Westenskow P, Splawski I, Timothy KW, Keating MT, Sanguinetti MC. Compound mutations: A common cause of severe long-QT syndrome. Circulation. 2004;109:1834-1841.
26. Girolami F, Ho CY, Semsarian C, Baldi M, Will ML, Baldini K, Torricelli F, Yeates L, Cecchi F, Ackerman MJ, Olivotto I. Clinical features and outcome of hypertrophic cardiomyopathy associated with triple sarcomere protein gene mutations. J Am Coll Cardiol. 2010;55:1444-1453.
27. Marian AJ. Modeling human disease phenotype in model organisms: "It's only a model!". Circ Res. 2011;109:356-359.
28. Marian AJ, Roberts R. On Koch's postulates, causality and genetics of cardiomyopathies. J Mol Cell Cardiol. 2002;34:971-974.